09 Jul Medication Adherence Technologies Not Working, JAMA Study Says
The following is an excerpt from an article that appeared on MobiHealthNews.
A new study of 1,500 patients casts doubt on the effectiveness of several promising medication adherence technologies and strategies, including connected pill bottles and lottery-based incentives.
The study, called the HeartStrong Study, was recently published in JAMA Internal Medicine. It was a year-long single-blind study of heart failure patients taking some combination of statins, aspirin, beta blockers and anti-platelet agents. About 1,000 patients used Vitality Glowcap connected pill bottles, daily lottery incentives that paid up to $50 for taking medications on time, and the option of enlisting friends or family to be informed if the connected pill bottle showed they skipped a dose. Additionally, the intervention group had access to a staff engagement advisor.
This article emphasis that technology itself cannot solve the problem of medication adherence. Patient engagement is critical, and these fancy technologies are no substitute for old-fashioned patient engagement.
CardioVisual allows for better engagement with patients, in the office and beyond, by empowering patients with the right information.